Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Head Neck. 2018 Feb 10;40(5):943–954. doi: 10.1002/hed.25057

TABLE 2.

Alteration Frequency of FA Pathway and FA Pathway-Associated Genes Within the 528-Patient TCGA HNSCC Provisional Dataset Retrieved Using cBioPortal.65,66 (Color-coding of genes in the table corresponds to color-coding of gene products in Figure 1 depicting the FA-pathway)

Gene (Alias) Number of Cases Altered (504 Total) Percent of Cases Altered

FA Pathway
FANCA 11 2.20%
FANCB 18 4%
FANCC 13 2.60%
FANCD1 (BRCA2) 27 5%
FANCD2 13 2.60%
FANCE 3 0.60%
FANCF 5 1%
FANCG 26 5%
FANCI 9 1.80%
FANCJ (BRIP1) 15 3%
FANCL 6 1.20%
FANCM 14 2.80%
FANCN (PALB2) 8 1.60%
FANCO (RAD51C) 3 0.60%
FANCP (SLX4) 10 2%
FANCQ (ERCC4) 5 1%
FANCS (BRCA1) 13 2.60%

FA Pathway-Associated
BRCA2 27 5%
BRCA1 13 2.60%
RB 28 6%
ATR 76 15%